Impact of ICU on the Quality of Life in Cancer Patients (QdV-ONCOREA)

Grenoble Alpes University Hospital Center (CHU)

Status: Completed

Conditions: Solid Tumor, Adult

Treatments: Other: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT04310033

2019-A03307-40 (Other Identifier)

38RC19.420

Details and patient eligibility

About

This is an observational, prospective, monocentric, case-control study. Investigators aim to compare the quality of life and oncological treatment strategy in cancer patients admitted or not in ICU.

Full description

Inclusion of cancer patients (cases) at discharge of surgical, cardiovascular and thoracic and medical ICU of the Grenoble Alpes University Hospital.

Cases will be matched with cancer patients identified in oncologist's consultation.

Inclusion of controls from oncologist consultations (2 controls for 1 case) For cases and controls, medical data will be collected at inclusion, 3 and 6 months.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• > 18 ans
• Non-opposition of the patient or relatives
• Lung, head and neck or colorectal cancer
• Non scheduled ICU admission
• At least 24 hours of ICU stay
• Alive at ICU discharge
• Able to answer by phone to quality of life questionary

Exclusion criteria

• Unable to answer by phone to quality of life questionary
• Patient participating in another clinical study that could interfere with the results of the study

Trial design

60 participants in 2 patient groups

Cases

Description:

* \> 18 years old * Non-opposition of the patient or relatives * Lung, head and neck or colorectal cancer * Non scheduled ICU admission * At least 24 hours of ICU stay * Alive at ICU discharge * Able to answer by phone to quality of life questionary

Treatment:

Other: Questionnaires

Controls

Description:

Cancer patients not admitted in ICU, matched with the cases according to * the type of primary cancer * the presence or absence of oncogenic addiction * the setting of anticancer treatment (curative/palliative) * the line of anticancer treatment (none/L1/L2-L3/\>L3).

Treatment:

Other: Questionnaires